EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in non-small cell lung cancer cells

Overexpression of ETS-homologous factor (EHF) in non-small cell lung cancer (NSCLC) is associated with poor patient prognosis. To explore the mechanism of the effect of EHF in NSCLC, EHF expression was examined in NSCLC and its role in cell proliferation, invasion, cell cycle, and apoptosis of NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lei, Yang, Tian, Zhang, Shuo, Liang, Yiqian, Shi, Puyu, Ren, Hui, Hou, Peng, Chen, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072815/
https://www.ncbi.nlm.nih.gov/pubmed/33907840
http://dx.doi.org/10.3892/or.2021.8053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072815/
https://www.ncbi.nlm.nih.gov/pubmed/33907840
http://dx.doi.org/10.3892/or.2021.8053

Ejemplares similares